Cambongga, Estephanie O.
HRN: 28-71-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
CEFUROXIME 750MG (VIAL)
03/20/2026
03/27/2026
IV
750MG
Q8H
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: